Interline Therapeutics

Interline Therapeutics

Interline Therapeutics is a drug discovery company focused on systematically elucidating protein communities to define molecular mechanisms of disease. The company aims to create a platform to discover, understand and re-engineer protein interactions to find new approaches to treat debilitating diseases. Funded by Foresite Capital and ARCH Venture Partners, and led by CEO Zach Sweeney, Interline is based in South San Francisco, CA.